Clinical & field news
Trial readouts, disease burden and what the pipeline is tracking.

GLP-1 Pipeline 2026 Update: What Research Labs Track
The GLP-1 pipeline 2026 spans semaglutide, tirzepatide, and retatrutide research. See which compounds, formulations, and QC methods labs should track now.
Zepbound Reversed Prediabetes, Prevented Progression to Type 2 for Nearly Everyone, Study Shows
Excitement is sweeping through the medical field thanks to a major study that could change how we handle diabetes prevention.
Tirzepatide: The Next Generation in Weight & Metabolic Health
Introduction: Why Metabolism Matters More Than Willpower Metabolic Foundations For decades, weight management advice has centered primarily on diet and
The Growing Burden of Diabetes and Obesity
Exploring Peptides for Metabolic Health: Advances in Research on Diabetes and Obesity Metabolic disorders such as type 2 diabetes and
Tirzepatide: Advancing Research in Peptide Science
Introduction Tirzepatide has emerged as a prominent subject of interest within peptide research due to its distinctive pharmacological profile and